Free shipping on all orders over $ 500

Mozavaptan

Cat. No. M1917

All AbMole products are for research use only, cannot be used for human consumption.

Mozavaptan Structure
Synonym:

OPC-31260

Size Price Availability Quantity
Free Sample (0.5-1 mg)  USD 0 In stock
10mM*1mL in DMSO USD 50  USD50 In stock
5mg USD 36  USD36 In stock
10mg USD 50  USD50 In stock
25mg USD 90  USD90 In stock
50mg USD 140  USD140 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

Mozavaptan (OPC-31260) is a novel, orally effective, nonpeptide vasopressin V2 receptor antagonist. The V2 receptor subtype is important in water retention, cardiac remodeling in congestive heart failure (CHF), and renal hemodynamic alterations, and is considered a target for polysystic kidney disease. Mozavaptan (OPC-31260) inhibited the antidiuretic action of exogenously administered AVP in water-loaded, alcohol-anaesthetized rats in a dose-dependent manner. Mozavaptan (OPC-31260) caused a competitive displacement of [3H]-AVP binding to both V1 and V2 receptors with IC50 values of 1.2 ± 0.2 × 10-6 M and 1.4 ± 0.2 × 10-8 M, respectively.

Chemical Information
Molecular Weight 427.53
Formula C27H29N3O2
CAS Number 137975-06-5
Solubility (25°C) DMSO 5 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Li-Hua Xu, et al. Inner Ear Arginine Vasopressin-Vasopressin Receptor 2-Aquaporin 2 Signaling Pathway Is Involved in the Induction of Motion Sickness

[2] Essam Ezzeldin, et al. UPLC/MS-MS assay development for estimation of mozavaptan in plasma and its pharmacokinetic study in rats

[3] Tetsuo Tamura, et al. Small cell gall bladder carcinoma complicated by syndrome of inappropriate secretion of antidiuretic hormone (SIADH) treated with mozavaptan

[4] Carles Villabona. Vasopressin receptor antagonists: the vaptans

Related Vasopressin Receptor Products
Tolvaptan

Tolvaptan is a selective, competitive arginine vasopressin receptor 2 antagonist with an IC50 of 1.28μM for the inhibition of AVP-induced platelet aggregation.

Conivaptan hydrochloride

Conivaptan hydrochloride is a non-peptide vasopressin receptor antagonist, which can inhibit V1A receptor in rat liver and V2 receptor in kidney with Ki values of 0.48 and 3.04 nM, respectively.

Atosiban Acetate

Atosiban (RW22164; Tractocile) Acetate is a nonapeptide, desamino-oxytocin analogue, and a competitive vasopressin/oxytocin receptor antagonist (VOTra). Atosiban inhibits the oxytocin-mediated release of inositol trisphosphate from the myometrial cell membrane.

L-371,257

L-371,257 is a potent and selective oxytocin receptor antagonist.

Antagonist G

Antagonist G is an anticancer peptide and it is also a potent vasopressin antagonist.

  Catalog
Abmole Inhibitor Catalog




Keywords: Mozavaptan, OPC-31260 supplier, Vasopressin Receptor, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.